Zhongren Wu

472 total citations
14 papers, 193 citations indexed

About

Zhongren Wu is a scholar working on Molecular Biology, Animal Science and Zoology and Genetics. According to data from OpenAlex, Zhongren Wu has authored 14 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Animal Science and Zoology and 3 papers in Genetics. Recurrent topics in Zhongren Wu's work include Receptor Mechanisms and Signaling (6 papers), Virus-based gene therapy research (3 papers) and Pharmacological Effects and Assays (3 papers). Zhongren Wu is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Virus-based gene therapy research (3 papers) and Pharmacological Effects and Assays (3 papers). Zhongren Wu collaborates with scholars based in United States and China. Zhongren Wu's co-authors include Harold L. Drake, Steven L. Daniel, Arnold E. Ruoho, Yong Diao, Weidong Xiao, David S. Thiriot, Qizhao Wang, LinShu Liu, Jenni Firrman and Gerard M. McGeehan and has published in prestigious journals such as Biochemistry, Scientific Reports and Biochemical Journal.

In The Last Decade

Zhongren Wu

14 papers receiving 180 citations

Peers

Zhongren Wu
Kwiwan Jeong South Korea
Pradeep K. Chatterjee United States
William Bottomley United Kingdom
Jian-Ying Zhou United States
Clemens C. Heikaus United States
John Hintze Denmark
Zhongren Wu
Citations per year, relative to Zhongren Wu Zhongren Wu (= 1×) peers Zhichao Tang

Countries citing papers authored by Zhongren Wu

Since Specialization
Citations

This map shows the geographic impact of Zhongren Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongren Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongren Wu more than expected).

Fields of papers citing papers by Zhongren Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongren Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongren Wu. The network helps show where Zhongren Wu may publish in the future.

Co-authorship network of co-authors of Zhongren Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongren Wu. A scholar is included among the top collaborators of Zhongren Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongren Wu. Zhongren Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rong, Meng, Wei Zeng, Feng Guan, et al.. (2024). Research on low carbon welding scheduling based on production process. Scientific Reports. 14(1). 28704–28704. 1 indexed citations
2.
Wang, Qizhao, Zhongren Wu, Junping Zhang, et al.. (2017). A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors. Molecular Therapy — Methods & Clinical Development. 7. 146–156. 29 indexed citations
3.
Wang, Qizhao, Jenni Firrman, Zhongren Wu, et al.. (2016). High-Density Recombinant Adeno-Associated Viral Particles are Competent Vectors for In Vivo Transduction. Human Gene Therapy. 27(12). 971–981. 16 indexed citations
4.
Wang, Qizhao, Biao Dong, Jenni Firrman, et al.. (2016). Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors. Molecular Therapy — Methods & Clinical Development. 4. 149–158. 12 indexed citations
5.
Simpson, R. David, Jing Yuan, Zhenrong Xu, et al.. (2011). Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility. ACS Medicinal Chemistry Letters. 2(10). 747–751. 29 indexed citations
6.
Wu, Zhongren, et al.. (2008). Purification and characterization of recombinant human renin for X-ray crystallization studies. BMC Biochemistry. 9(1). 19–19. 8 indexed citations
7.
Wu, Zhongren, et al.. (2004). Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293. Protein Expression and Purification. 37(1). 53–60. 4 indexed citations
8.
Sievert, Michael K., et al.. (2003). UV Crosslinking of Adrenergic Receptors and Ligands: Detection by SDS-PAGE. Humana Press eBooks. 126. 315–327. 1 indexed citations
9.
Archer, Sharon J., Daniel M. Camac, Zhongren Wu, et al.. (2002). Hepatitis C Virus NS3 Protease Requires Its NS4A Cofactor Peptide for Optimal Binding of a Boronic Acid Inhibitor as Shown by NMR. Chemistry & Biology. 9(1). 79–92. 19 indexed citations
10.
Wu, Zhongren, David S. Thiriot, & Arnold E. Ruoho. (2001). Tyr199 in transmembrane domain 5 of the β2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist. Biochemical Journal. 354(3). 485–485. 9 indexed citations
11.
Wu, Zhongren, David S. Thiriot, & Arnold E. Ruoho. (2001). Tyr199 in transmembrane domain 5 of the β2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist. Biochemical Journal. 354(3). 485–491. 7 indexed citations
12.
Wu, Zhongren & Arnold E. Ruoho. (2000). A High-Affinity Fluorenone-Based β2-Adrenergic Receptor Antagonist with a Photoactivatable Pharmacophore. Biochemistry. 39(42). 13044–13052. 8 indexed citations
13.
Yu, Fu‐Li, et al.. (1991). Evidence for the covalent binding of aflatoxin B1-dichloride to cytosine in DNA. Carcinogenesis. 12(6). 997–1002. 11 indexed citations
14.
Daniel, Steven L., Zhongren Wu, & Harold L. Drake. (1988). Growth of thermophilic acetogenic bacteria on methoxylated aromatic acids. FEMS Microbiology Letters. 52(1-2). 25–28. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026